The Infectious Diseases Society of America (IDSA) made recommendations on using drugs to treat COVID-19, while cardiac groups warned about risks of arrhythmias with hydroxychloroquine and azithromycin.
To me, this was COVID-19 showing its ugly “face” as a formidable virus that is difficult to manage.
The Infectious Diseases Society of America (IDSA) updated its recommendations on treatment and management of inpatients with COVID-19. An article by mental health experts offered guidance on talking with bereaved family members.
My mother's hospital had decided to all halt all visitors to protect the patients.
The pace, the stress, the facelessness behind masks, and the lack of any real chance to connect made the patients blur together in my mind like never before.
Peer-reviewed details on the recent trial of dexamethasone were released, and two new trials found no benefit to early treatment with hydroxychloroquine. Positive data from three vaccine trials were also published, as was another study of tocilizumab
Hospitalists describe the steps they've taken to prepare for the pandemic.
Recent articles offered advice on avoiding overuse in medicine and viral spread, including during ventilation. A study found mood problems and fears among physicians treating COVID-19, while mental health experts offered some solutions.
Hospitalists share strategies for pandemic problems.
Concerns about visas and residency add to pressures of hospitalist practice.